Ryan M. Rourke Reed

Partner - Boston

Ryan Reed
Download Media Photo

Contact Information


Ryan Reed is a partner in the firm’s Business Department. He focuses on general corporate and securities law matters and mergers and acquisitions. He represents public and private companies in a broad range of strategic transactions including matters regarding formation, founder’s arrangements, public and private equity and debt financings, employment agreements, exits and general corporate governance. Ryan also advises public companies with respect to ongoing periodic and current reporting requirements; Section 16 matters; annual and special stockholder meetings; and coordination of responses to any related SEC review regarding same. He also advises non-profit organizations with respect to formation and general governance matters, as well as non-profit mergers and collaborations.

Education:

  • Boston College Law School, J.D., cum laude, 2011
  • University of Notre Dame, B.A., cum laude, 2006

Languages:

English

Representative Experience

  • The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, in the acquisition of Green Roads worth up to $60M.
  • Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a multi-state cannabis operator
    • in closing an underwritten public offering worth of approximately US$228 million of subordinate voting shares
    • in its C$115.5 million offering of subordinate voting shares
  • Organogenesis Holdings Inc. (Nasdaq: ORGO) and its wholly owned subsidiary Organogenesis Inc., a leading regenerative medicine company in:
    • its $64.7 million underwritten public offering of Class A common stock
    • its $50.3 million underwritten public offering of Class A common stock
    • its warrant exchange offer and consent solicitation
    • a SPAC IPO/reverse merger of Organogenesis Inc. with and into a wholly owned subsidiary of Avista Healthcare Public Acquisition Corp. (AHPAC), with Organogenesis Inc. surviving the merger and AHPAC changing its name to Organogenesis Holdings Inc.
    • its acquisition of NuTech Medical
  • Ethos Cannabis, a multi-state cannabis operator, in connection with its acquisition of dispensaries in Pennsylvania and Maryland from 4Front Ventures Corp. 
  • Sensata Technologies, Inc., an indirect, wholly owned subsidiary of Sensata Technologies Holding plc (NYSE: ST) in its:
    • August 2020 Rule 144A offering of $750 million in aggregate principal amount of 3.750% senior notes due 2031
    • September 2019 Rule 144A offering of $450 million in aggregate principal amount of 4.375% senior notes due 2030
  • Entegris, Inc. (NASDAQ:ENTG), a world-class supplier of advanced materials and process solutions for the semiconductor and other high-tech industries, in its April 2020 Rule 144A offering of $400 million in aggregate principal amount of 4.375% senior notes due 2028 
  • New England Treatment Access, LLC (NETA), a leading Massachusetts-based cannabis company, in its sale to Surterra Wellness.
  • Enanta Pharmaceuticals, Inc. (Nasdaq: ENTA) in its initial public offering of common stock which raised $64.0 million for Enanta’s development of new compounds for combination treatment regimens for Hepatitis C.
  • Applied Genetic Technologies Corporation (Nasdaq: AGTC) in its: 
    • $37.4 million underwritten public offering of common stock
    • sales agreement with Cantor Fitzgerald & Co. for an up to $25 million ATM offering
  • Zosano Pharma Corporation (Nasdaq: ZSAN), a clinical-stage biopharmaceutical company:
    • in its $50.0 million underwritten public offering of common stock
    • in its $29.3 million underwritten public offering of common stock
    • in its common stock purchase agreement with Lincoln Park Capital Fund, LLC for up to $35 million
    • in its $7.5 million PIPE of units (common stock and warrants) with warrants exercisable for an additional $14.4 million
  • Bolt Technology Corporation (Nasdaq: BOLT), a leading supplier of marine seismic energy sources and replacement parts for offshore energy exploration, in its sale to Teledyne Technologies Incorporated.
  • Dyax Corp. (Nasdaq: DYAX), a biopharmaceutical company, in its $30,000,000 registered direct offering to existing institutional investors.
  • Parsagen Diagnostics Inc., a medical device company, in its sale to QIAGEN N.V.
  • Xcovery Holding Company LLC, a biopharmaceutical company, in multiple financing rounds, including a strategic investment by and collaboration with Betta Pharmaceuticals.
  • Tyrogenex, Inc., a biopharmaceutical company, in multiple financing rounds, including a strategic investment by Brace Pharma, the U.S. investment company of EMS S/A.
  • Accela, Inc., the leading provider of cloud-based civic engagement solutions for government, in connection with its acquisition of each of PublicStuff, Springbrook Software, SoftRight, Decade Software, Kinsail and Envista.
  • FoodShouldTasteGood, Inc., a natural foods maker, in its sale to General Mills, Inc.
  • Healthjump, Inc., in connection with its acquisition of substantially all of the assets of DataTrade Solutions, Inc., a Healthcare IT consulting, development and support company.
  • Innovent Biologics, Inc., a Chinese biopharmaceutical company in multiple venture financing rounds.
  • Evaporated Metal Films Corporation, a subsidiary of Dynasil Corporation of America (Nasdaq: DYSL), in connection with its acquisition of substantially all of the assets of DichroTec Thin Films, LLC, a Rochester, NY-based optical thin film coating manufacturer.
  • Dynasil Corporation of America (Nasdaq: DYSL), in connection with the sale of its X-Ray Florescence (XRF) Lead Paint Detector product line to PROTEC Instrument Corporation, the U.S. subsidiary of its long-time distributor, French firm Laboratories PROTEC S.A.
  • RMD Instruments Corp., a subsidiary of Dynasil Corporation of America (Nasdaq: DYSL), in connection with the sale of its Navigator gamma probe business to Dilon Technologies Inc.
  • James Russell Engineering Works, a manufacturer of aluminum and stainless-steel cryogenic transport trailers used for hauling liquid oxygen, nitrogen, argon, hydrogen, and liquefied natural gas, in connection with the sale of substantially all of its assets to Worthington Industries Inc.
  • RCN Telecom Services, LLC in its Rule 144A and Regulation S Senior Note Offering.
  • Archimedes Systems, Inc., a personal financial planning company, in its sale to Wealth Management Systems Inc.
  • ABRY Partners, in connection with its minority investment in One Source Networks, a cloud and managed services partner for large enterprises.
  • Corelink Data Centers, LLC, in connection with the sale of substantially all of its assets to the Zayo Group.
  • OPNET Technologies, Inc. in its strategic acquisition of Clarus Systems, Inc.
  • Columbia Capital, in its strategic investment in IntelliBatt, a California-based battery back-up and predictive services company.
 

Professional Experience

  • Summer Clerk, Honorable Mary Orfanello, Quincy District Court

Honors

  • 2016 Boston’s Future Leaders Program, a year-long program led by the Greater Boston Chamber of Commerce for 80 of the region’s most talented emerging professionals that includes sessions at both Harvard Business School and Suffolk University’s Sawyer Business School
  • Boston College International and Comparative Law Review, Articles Editor

Involvement

  • Member, American Bar Association
  • Member of the Board of Directors of The Marble Collection, a Massachusetts non-profit organization focused on the cultivation of creativity and excellence in the arts by engaging teen artists and writers through a publication process that affirms their voices and deepens their learning
  • Supporter and Former Teacher, Paraclete Center (an after-school program in South Boston)
  • Supporter and Former Donations and Accounting Manager, Maranyundo Initiative (a Boston-based non-profit that built and supports an all-girls middle school (and soon to be high-school as well) in Nyamata, Rwanda)
  • Panelist, “SPACs: A Fad or Here to Stay?” at the Foley Hoag M&A Forum (February 2021) 
  • Co-presented “Benefit Corporations: Massachusetts, Delaware, and Why Tax-Exempt Organizations Should Use Them” at the Boston Bar Association (March 2014)
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts